DOUBLE BARRIER: integrating AI-driven multi-omics diagnostics and next-generation prevention to combat bacterial infections
| Reference number | |
| Coordinator | RISE Research Institutes of Sweden AB |
| Funding from Vinnova | SEK 1 000 000 |
| Project duration | November 2025 - December 2026 |
| Status | Ongoing |
| Venture | Deepened international collaborations |
| Call | Deepened collaboration with USA, UK and Singapore within Health and Life Science |
Purpose and goal
The purpose of this project is to develop the concept DOUBLE BARRIER, which aims to integrate AI-driven multi-omics diagnostics and next-generation prevention strategies to combat bacterial infections and antimicrobial resistance (AMR).
Expected effects and result
The DOUBLE BARRIER approach will enable faster and more precise data-rich diagnostics, supporting tailored treatments of infectious diseases while simultaneously improving and guiding prevention strategies.
Planned approach and implementation
This is a multidisciplinary project in which RISE Research Institutes of Sweden (Sweden, coordinator), Sahlgrenska University Hospital (Sweden), Veirulence Ltd. (UK), Imperial College London (UK) and The National Institutes of Health (USA) will collaborate closely, leveraging their facilities and personal to advance the concept DOUBLE BARRIER and secure additional funding. The project includes a pilot study which will be conducted across facilities in all three participating countries.